In the U.S., someone is infected with an antimicrobial resistance (AMR) organism every 11 seconds. Optum is proud to be a part of the Fleming Initiative to help reduce the consequences of AMR infection and help people live healthier lives.
Imagine a future where antimicrobial resistance (AMR) claims more lives than cancer. This could happen in just twenty-six years without prompt action. In 1928, Alexander Fleming discovered penicillin, which increased human life expectancy by 23 years. Nearly 100 years on, antibiotic resistant bacteria are on the rise. In the U.S., someone is diagnosed with AMR every 11 seconds and dies from it every 15 minutes, and this figure is only going to grow. By 2050, AMR is projected to cause more deaths than cancer, disproportionately affecting the global south and other disadvantaged populations. Last week at the United Nations General Assembly fringe sessions, we announced that Optum will be the primary data and analytics partner for the Fleming Initiative. Led by Professor the Lord Darzi of Denham OM KBE PC FRS, this initiative aims to raise awareness and develop research, technology, and policy to combat #AMR. Together, we will collaboratively find #innovative solutions to make the healthcare system better for everyone.